Drug profile · INN
niclosamide
NICLOCIDE
niclosamide (NICLOCIDE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — niclosamide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 1
- Data quality
- 0.84
Quick answer
niclosamide (NICLOCIDE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN niclosamide
Brand NICLOCIDE
Mechanism DNA inhibitor
Target DNA
Route ORAL
Formulation TABLET, CHEWABLE
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is niclosamide?
niclosamide (NICLOCIDE) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for niclosamide?
NICLOCIDE is a marketed brand name for niclosamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of niclosamide?
niclosamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.